BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Braillon A. Is the American Association for the Study of Liver Diseases recommendation for hepatocellular carcinoma screening a cul-de-sac? World J Gastroenterol 2013; 19(21): 3369-3370 [PMID: 23745043 DOI: 10.3748/wjg.v19.i21.3369]
URL: https://www.wjgnet.com/1007-9327/full/v19/i21/3369.htm
Number Citing Articles
1
Alain Braillon. Screening for Hepatocellular Carcinoma: Where Is the Inconsistency?The American Journal of Medicine 2015; 128(3): e25 doi: 10.1016/j.amjmed.2014.09.025
2
Tom Sutherland, Jane Watts, Marno Ryan, Angela Galvin, Faye Temple, Jason Vuong, Andrew Francis Little. Diffusion‐weighted MRI for hepatocellular carcinoma screening in chronic liver disease: Direct comparison with ultrasound screeningJournal of Medical Imaging and Radiation Oncology 2017; 61(1): 34 doi: 10.1111/1754-9485.12513
3
Arne Nørgaard Eskesen, Kristian Bjøro, Einar Martin Aandahl, Pål Dag Line, Espen Melum. Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway—A population-based cohort studyCancer Epidemiology 2014; 38(6): 741 doi: 10.1016/j.canep.2014.10.005
4
Jens U. Marquardt, Marc Nguyen-Tat, Peter R. Galle, Marcus A. Wörns. Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver CirrhosisVisceral Medicine 2016; 32(2): 110 doi: 10.1159/000445407
5
Hai-Yong Chen, Yao-Min Chen, Jian Wu, Fu-Chun Yang, Zhen Lv, Xiao-Feng Xu, Shu-Sen Zheng. Expression of FOXO6 is Associated With Oxidative Stress Level and Predicts the Prognosis in Hepatocellular CancerMedicine 2016; 95(21): e3708 doi: 10.1097/MD.0000000000003708